PMI · Picard Medical, Inc.
$4.34
-4.12 (-48.70%)
At close · Sep 1
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these conditions, we have concluded that there is substantial doubt over our ability to continue as a going concern as conditions and events, considered in the aggregate, indicate it is probable we will be unable to meet our obligations as they become due within one year after the date that the financial statements included in this filing are issued.”View the 10-Q filed Aug 19, 2026
Market Cap
$20.58M
Shares
2.34M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Patrick NJ Schnegelsberg | Former Chief Executive Officer | $400,000 |
| Matt Schuster | Chief Operating Officer | $220,000 |
| Bernard Skaggs | Former Chief Financial Officer | $200,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Patrick NJ Schnegelsberg | Former Chief Executive Officer | $1,648,946 |
| Matt Schuster | Chief Operating Officer | $529,442 |
| Bernard Skaggs | Former Chief Financial Officer | $472,617 |